Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 34Polycystic Ovary Syndrome 2Infertility 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Prostatic Intraepithelial Neoplasia 1Primary Dysautonomias 1Overweight 1Ovarian Neoplasms 1Oligomenorrhea 1Metabolic Syndrome 1Kidney Diseases 1Insulin Resistance 1Hypertension 1Hyperandrogenism 1Hirsutism 1Castration-resistant Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Anovulation 1Amenorrhea 1Adenocarcinoma 1

Interventions

Metformin 4Inositol 3drospirenone and ethinyl estradiol combination 2Progesterone 2Folic Acid 2Ethinyl Estradiol 2Cyproterone Acetate 2salicylsalicylic acid 1maltodextrin 1licogliflozin 1Yoga 1Waist-Hip Ratio 1Waist Circumference 1Time 1Thioctic Acid 1Sugars 1Spironolactone 1Sodium Salicylate 1Phlebotomy 1Lactalbumin 1Inulin 1Insulin 1Glycoprotein Hormones, alpha Subunit 1Flutamide 1Estrogens 1Estradiol 1Doxycycline 1Clomiphene 1Cardiovascular Physiological Phenomena 1Body Mass Index 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperandrogenism × Flutamide × Clear all
NCT01889199 2025-01-10

Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS Women

University of California, Los Angeles

Phase 2 Completed
23 enrolled 12 charts

Amenorrhea, Anovulation, Hirsutism, Oligomenorrhea, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡